相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
Argonde C. van Harten et al.
ALZHEIMERS & DEMENTIA (2013)
Molecular Structure of β-Amyloid Fibrils in Alzheimer's Disease Brain Tissue
Jun-Xia Lu et al.
CELL (2013)
Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice
Katherine D. LaClair et al.
MOLECULAR NEURODEGENERATION (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology
Grietje Krabbe et al.
PLOS ONE (2013)
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
Philip B. Verghese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Ina Tesseur et al.
SCIENCE (2013)
The effect of amyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes
Sandra D. Mulder et al.
EXPERIMENTAL NEUROLOGY (2012)
The role of astrocytes in amyloid β-protein toxicity and clearance
Dietmar Rudolf Thal
EXPERIMENTAL NEUROLOGY (2012)
Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels
C. Y. Daniel Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent Aβ Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice
Nga Bien-Ly et al.
JOURNAL OF NEUROSCIENCE (2012)
Association of ApoE and LRP mRNA levels with dementia and AD neuropathology
Afia Akram et al.
NEUROBIOLOGY OF AGING (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where
Aaron Y. Lai et al.
FUTURE NEUROLOGY (2012)
The Early Involvement of the Innate Immunity in the Pathogenesis of Late-onset Alzheimer's Disease: Neuropathological, Epidemiological and Genetic Evidence
P. Eikelenboom et al.
CURRENT ALZHEIMER RESEARCH (2011)
Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brains
Cristian A. Lasagna-Reeves et al.
FEBS LETTERS (2011)
Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis
Jungsu Kim et al.
JOURNAL OF NEUROSCIENCE (2011)
Heparan Sulphate Proteoglycan and the Low-Density Lipoprotein Receptor-Related Protein 1 Constitute Major Pathways for Neuronal Amyloid-β Uptake
Takahisa Kanekiyo et al.
JOURNAL OF NEUROSCIENCE (2011)
Apolipoprotein E protects cultured pericytes and astrocytes from D-Aβ1-40-mediated cell death
Ilona B. Bruinsma et al.
BRAIN RESEARCH (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects
G. C. Chiang et al.
NEUROLOGY (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Binding and Uptake of Aβ1-42 by Primary Human Astrocytes In Vitro
Henrietta M. Nielsen et al.
GLIA (2009)
Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis
Shweta Mandrekar et al.
JOURNAL OF NEUROSCIENCE (2009)
A SNP in the ACT gene associated with astrocytosis and rapid cognitive decline in AD
O. Belbin et al.
NEUROBIOLOGY OF AGING (2008)
Lipoprotein receptor-related protein-1 mediates amyloid-β-mediated cell death of cerebrovascular cells
Micha M. M. Wilhelmus et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Minocycline does not affect amyloid β phagocytosis by human microglial cells
Atoosa Familian et al.
NEUROSCIENCE LETTERS (2007)
Clusterin: A protective mediator for ischemic cardiomyocytes?
PAJ Krijnen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Apolipoprotein J (clusterin) activates rodent microglia in vivo and in vitro
Z Xie et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Amyloid Associated Proteins in Alzheimer's and Prion Disease
R. Veerhuis et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease
MI Fonseca et al.
JOURNAL OF NEUROSCIENCE (2004)
Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders
J van Horssen et al.
LANCET NEUROLOGY (2003)
The apolipoprotein E ε2 allele and decline in episodic memory
RS Wilson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Establishment of microglial cell cultures derived from postmortem human adult brain tissue: Immunophenotypical and functional characterization
CJA De Groot et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2001)
Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated αβ deposits in the human entorhinal cortex
DR Thal et al.
ACTA NEUROPATHOLOGICA (2000)
Astroglial expression of human α1-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice
L Mucke et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Complement component C1q modulates the phagocytosis of A beta by microglia
SD Webster et al.
EXPERIMENTAL NEUROLOGY (2000)
分享论文
